INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $242,000 | -31.4% | 4,324 | -36.6% | 0.00% | 0.0% |
| Q2 2022 | $353,000 | -28.8% | 6,824 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $496,000 | -40.5% | 6,824 | -3.2% | 0.00% | -50.0% |
| Q4 2021 | $833,000 | -11.9% | 7,047 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $945,000 | -17.2% | 7,047 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $1,141,000 | +28.6% | 7,047 | -36.3% | 0.00% | +50.0% |
| Q1 2021 | $887,000 | +154.9% | 11,055 | +72.6% | 0.00% | +100.0% |
| Q4 2020 | $348,000 | +319.3% | 6,405 | +112.1% | 0.00% | – |
| Q2 2018 | $83,000 | +1.2% | 3,020 | -22.3% | 0.00% | – |
| Q1 2018 | $82,000 | +41.4% | 3,889 | +29.6% | 0.00% | – |
| Q4 2017 | $58,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |